Early Look

Tuesday, November 3, 2026

U.S. futures are mixed as Dow futures tumble following mixed earnings/guidance results from Apple (AAPL) overnight, sending shares down roughly 4% as the company warned that rising memory costs would squeeze gross margins. Meanwhile the tech heavy Nasdaq looks to rebound after tumbling over 1% Monday and over 5% in October led by a further pullback in semi chip and AI names. Attention turns to politics this morning (in addition to earnings) as prediction market odds of Democrats sweeping midterms House and Senate rise above 75% on Election Day. The contract for a split Congress with a Republican Senate and Democratic House fell to 20%, while a Republican sweep stood at 6%. While politics is in focus there are a few economic data points today including monthly JOLTs job opening data and Factory orders, as well as another barrage of corporate earnings.

In Asian markets, The Nikkei Index decline d-208 points to 63,081, the Shanghai Index fell -29 points to 3,608, and the Hang Seng Index rose 132 points to 23,535. In Europe, the German DAX is…while the FTSE 100. Oil prices rebound 1.75% to $98.16 per barrel for WTI as an Iranian official said Tehran and Washington remained far from a deal to end the war and the US struck Iran's Qeshm Island according to reports. Both Brent and WTI had dropped more than 7% on Monday as talks between Iranian and Qatari officials lifted hopes for an end to the US-Israeli war with Iran.

The S&P 500 ended lower on Monday as oil prices tumbled on optimism about a potential US-Iran peace agreement, while Apple shares dipped ahead of the iPhone maker's quarterly report and investors awaited Tuesday's US midterm elections. Seven of the 11 S&P 500 sector indexes rose, led by consumer discretionary (XLY) up 2.25%, followed by a 1.83% gain in materials (XLB) while the energy index (XLE) fell 4%, followed by Technology (XLK) down nearly -3%. Longer-dated US Treasury yields moved lower and Brent crude/WTI prices fell over 7% as Iran indicated it was open to peace talks after eight months of war in the Middle East that have kept energy prices elevated and stoked inflation.

The Dow finished higher on Monday, and early in the session, the S&P 500 and Nasdaq gained on the first day of trading in November. In October, the Nasdaq fell 5.3% for the month following a selloff on Friday related to worries that massive spending on AI infrastructure is outpacing near-term cash generation.

• The Dow Jones Industrial Average rose 213.67 points, or 0.41%, to 51,983.98
• The Nasdaq Composite tumbled -272.68 points, or 1.07%, to 25,164.32
• The Russell 2000 Index declined -6.00 points, or 0.21% to 2,805.84

• 8:55 AM ET                   Johnson/Redbook Weekly Sales
• 10:00 AM ET                 Durable Goods, M/M for September
• 10:00 AM ET                 JOLTs Job openings for September…est. 7.1M (prior 7.079M)
• 10:00 AM ET                 Factory Orders M/M for September…est. +1.2%
• 4:30 PM ET API Weekly Inventory Data

• Earnings After the Close: ACEL ADUS AFG AIG AIZ ALAB ALIT AMD AMGN AMWL ANDE ANET ANGI AQST ARDX ASH ATRC BKNG BXC CAR CBLL CHCT CORT CPNG CRCT CURLF CXDO DEI DOX DRH DUOL EVTC FBIN FLYW FRSH FTEK FTK GEF GOOD GSM GXO HL HMN HURN IFF IOSP IPI ITUB JELD JKHY JXN KODK LMB LTC MCY METC MIRM MOD MOS MQ MTDR MTW NVTS OHI OUST OVV PARR PCOR PRIM PRU PXED QDEL RARE RRR RWT RYAM SAFE SDRL SGHC SKY SM SMCI SPT SU SWIM SWKS TALO TOST TREE TRVG TSLX UFCS UNM USNA VRNS WTRG XYZ ZVRA

• Clorox Co (CLX) Q1 adj EPS $1.55 tops consensus $1.07; Q1 revs $1.91B vs. est. $1.88B; Q1 gross margin down 130 bps to 40.4% from 41.7% last year; Sees FY outlook for adj EPS of $5.70-$6.00 above consensus of $5.69; in fiscal year 2027, will lap 2026 inventory drawdown, which is expected to result in more than 3.5 points of benefit to net sales growth.
• Match Inc. (MTCH) Q3 EPS $0.73 vs. est. $0.72 (beat); revenue $891.232Mm vs. est. $892.468Mm (miss); adj. EBITDA $344.5Mm vs. est. $332.1Mm (beat), margin 39%; payers 13.8M, -5%; Q4 revenue outlook $865-875Mm vs. est. $871.4Mm (in line) and adj. EBITDA $327.5-332.5Mm vs. est. $327.8Mm (in line); FY26 revenue expected flat YoY and slightly above prior guidance midpoint, with adj. EBITDA margin 38.8% at Q4 guidance midpoints.

• BWX Technologies (BWXT) Q3 adj. EPS $1.26 vs. est. $1.19 (beat); revenue $953Mm vs. est. $970.4Mm (miss); adj. EBITDA $179.7Mm vs. est. $167.5Mm (beat); FCF $150.5Mm; FY26 revenue outlook $3.8B vs. est. $3.807B (in line), adj. EBITDA $667Mm vs est $660.56Mm (above), adj. EPS $4.72-4.77 vs. est. $4.74 (in line), and FCF $350-360Mm
• California Resources Corporation (CRC), and its carbon management business, Carbon TerraVault announced the signing of a memorandum of understanding with Bloom Energy (BE) to jointly evaluate and target the potential development of 1 gigawatt (GW) or more of solid-oxide fuel cell power generation paired with carbon capture and storage in California.
• CVR Energy (CVI) announces transformative transaction to acquire 2 refineries and marketing platform from Marathon Petroleum (MPC) for $4.20B plus net working capital. To buy 105,000 bpd st. Paul Park refinery in Minnesota and 72,000 bpd Mandan refinery in North Dakota.
• Diamondback Energy (FANG) Q3 adj. EPS $5.86 vs. est. $5.46; revenue $5.43B vs. est. $4.6B; adj. FCF $2.15B; oil production 525 MBO/d, flat QoQ, and total production 1,034 MBOE/d, +2% QoQ; Q4 oil production outlook 518-528 MBO/d and CAPEX $1.00-1.05B; FY26 oil production outlook about 524 MBO/d and CAPEX $3.95-4.00B; base dividend increased over 7%.
• Enovix Corporation (ENVX) files registration to offer up to $500M in securities.
• Transocean (RIG) Q3 adj EPS $0.02, in-line with consensus on revs $937M vs. est. $942.29M; sees FY26 revenue $3.900B-$3.950B vs. consensus $3.94B and FY26 capital expenditures $145M; said total backlog about $8B as of today, adding about $2B to contract backlog.
• Williams Company (WMB) Q3 adj. EPS $0.54 vs. est. $0.55 (miss); revenue $3.223B vs. est. $2.893B (beat); adj. EBITDA $2.04B vs est $2.017B (beat); operating cash flow $1.505B; FY26 adj. EBITDA outlook $8.3-8.5B vs. est. $8.466B , tracking toward upper half; FY26 growth CAPEX $7.3-7.9B.

• Realty Income (O) Q3 revs $1.62B vs. est. $1.53B; raises 2026 AFFO per share guidance to $4.45–$4.46; reaffirms 2026 investment volume target at $10.0B; expects 2026 occupancy above 98.5%
• UDR Inc. (UDR) Q3 FFO/share $0.65 vs. est. $0.64 (beat); revenue $424.581Mm vs. est. $428.633Mm (miss); Q4 FFO/share outlook $0.63-0.65 vs. est. $0.64 (in line); FY26 FFO/share outlook $2.54-2.56 vs. est. $2.53.
• Upwork Holdings (UPWK) Q3 adj. EPS $0.40 vs est $0.31 (beat); revenue $185.6Mm vs. est. $180.2Mm (beat); adj. EBITDA $63.8Mm vs. est. $52.3Mm (beat); FCF $53.9Mm; Q4 revenue outlook $169-177Mm vs. est. $174.8Mm (in line), adj. EBITDA $51-55Mm vs est $52.35Mm (in-line), and adj. EPS $0.30-0.32 vs. est. $0.33 (below); FY26 revenue outlook $742-750Mm vs est $742.2Mm (in-line/above) and adj. EPS $1.45-1.47 vs est $1.38.
• Vornado Realty (VNO) Q3 adj. FFO/share $0.65 vs. est. $0.64 (beat); revenue $467.657Mm vs. est. $461.996Mm.

• Healthpeak Properties (DOC) Q3 adj. FFO/share $0.44 vs. est. $0.43 (beat); revenue $820.892Mm vs. est. $736.787Mm (beat); FY26 diluted FFO/share outlook $1.76-1.78 vs est $1.76 (in-line/above)
• Hinge Health (HNGE) Q3 adj EPS $0.66 vs. est. $0.60; Q3 sales rose 52% y/y to $235M vs. est. $224.56M; raised full-year 2026 revenue guidance, now sees 50% yr/yr growth at midpoint; now sees FY26 sales $879M-$881M above prior $856M-$860M view (est. $861.5M).
• Jazz Pharma (JAZZ) Q3 adj. EPS ($3.88) vs. est. ($3.86); revenue $1.243B vs. est. $1.208B; adj. net loss $250.8Mm vs. est. loss $207.8Mm; Xywav revenue $482.8Mm; guides FY revs $4.775-4.85B vs est $4.719B and adj gr mgn 90.5-91.5%.
• Neurocrine Biosciences (NBIX) Q3 adj EPS $3.29 tops consensus $1.91 on revs $1.11B vs. est. $1.04B.
• Travere Therapeutics (TVTX) Q3 adj. EPS ($0.31) vs. est. ($0.06) (miss); revenue $224.563Mm vs. est. $195.292Mm (beat); product sales $220.196Mm; operating loss $68.105Mm; operating expenses $292.668Mm.
• Vertex Pharma (VRTX) Q3 adj. EPS $4.76 vs. est. $4.79; revenue $3.44B vs. est. $3.417B; adj. operating Income $1.41B; adj. net Income $1.21B; FY26 revenue outlook $13.15-13.25B vs. est. $13.245B.
• Waters (WAT) Q3 adj EPS $4.10 vs. est. $4.00 on sales $1.767B vs. est. $1.754B; raises FY26 adjusted EPS view to $14.60-$14.70 from $14.45-$14.65 and boosts FY26 revenue view to $6.48B-$6.5B from $6.42B-$6.48B, consensus $6.46B.

• Allison Transmission (ALSN) Q3 adj EPS $2.90 vs. est. $2.43; Q3 revs rose 121% y/y to $1.53B vs. est. $1.47B; said Higher volumes for medium-duty and Class 8 vocational trucks in North America On-Highway market drove record revenue; now expects 2026 net income of $645-$685M.
• Chemours Company (CC) Q3 adj EPS $0.21 vs. est. $0.27; Q3 sales $1.5B vs. est. $1.53B; Q3 adj Ebitda $200M vs. est. $193.6M, net income $31M; expects Q4 net sales to decline 5%-10% sequentially and forecasts Q4 adjusted EBITDA between $160M-$185M.
• Celanese Corp. (CE) Q3 adj. EPS $1.65 vs. est. $1.56 (beat); sales $2.556B vs. est. $2.622B (miss); EBITDA $548Mm vs est $540.17Mm (beat); operating Income $198Mm; raises FY26 adj. EPS outlook to $6.00-6.25 vs est $6.01; expects Q4 year-end seasonal moderation across both business
• DuPont de Nemours Inc (DD) Q3 sales $1.868B vs. est. $1.843B and Q3 adj EPS $2.09 vs. est. $1.87; Q3 operating EBITDA $469M vs. est. $449.4M; Q3 operating EBITDA margin 25.1%; guides FY operating EBITDA $1.785B vs. est. $1.762B and FY adj EPS $7.47-7.52 vs. est. $7.25.
• Hunstman Corp. (HUN) Q3 adj EPS $0.04 vs. est. $0.07; Q3 revs $1.72B vs. consensus $1.61B; Q3 operating income $39M, adj Ebitda $132M and net loss -$18M.

• Advanced Energy Industries (AEIS) Q3 adj EPS $3.65 vs. consensus $3.06 and revs rose 50% y/y to $696M vs. consensus $647.11M; sees Q4 adj EPS $3.90, plus or minus 30c, consensus $3.42 and sees Q4 revenue $735M, plus or minus $25M, vs. consensus $693.57M.
• Aehr Test Systems (AEHR) Q1 adj. EPS $0.28; record revenue $33.007Mm vs. est. $27.1Mm (beat); gross profit $15.7Mm; operating Income $6.05Mm; raises FY27 revenue outlook to $150Mm vs est $137.06Mm (above), triple FY26 revenue.
• Backblaze Inc. (BLZE) Q3 revs $46.7M vs. est. $44.6M; sees Q4 revs $49.8M-$50.2M vs. est. $47M and raises year sales view to $177.8M-$178.2M from prior $172M-$174M; said broad-based customer momentum drove 47% yr/yr growth in B2 Cloud Storage revenue.
• Cloudflare (NET) upgraded to Overweight from Neutral at JPMorgan with a $350 price target saying they see expansion among existing customers and sustained developer adoption of Cloudflare Workers, with revenue growth potentially accelerating to 35% or more over the medium term.
• Fabrinet (FN) Q1 adj EPS $4.34 vs. est. $4.20 and Q1 revs $1.47B vs. est. $1.41B; guides Q2 adj EPS $4.77-$4.92 vs. est. 44.43 and revs $1.6B-$1.65B vs. est. $1.48B.
• Lattice Semiconductor (LSCC) Q3 adj. EPS $0.72 vs. est. $0.55; record revenue $291.035Mm vs. est. $255.5Mm, +118% YoY; adj. gross margin 70.9%; Q4 revenue outlook $335Mm vs. est. $293.2Mm and adj. EPS $0.82-0.86 vs. est. $0.65
• Nvidia (NVDA) is ordering its data centre partners to reduce exposure to Chinese customers in a move that further restrains China's ability to keep up with US rivals as the race between the world's two AI superpowers intensifies. - Financial Times
• On Semi (ON) announced that it has entered into an agreement to acquire Ferric, Inc. for $600M in cash, plus up to $175 million in contingent consideration upon achievement of certain revenue milestones; reported Q3 adj EPS $0.90 vs. est. $0.88 and revs $1.72B vs. est. $1.7B; raises 2030 AI data center revenue target to more than $3B.
• Oracle (ORCL) 86.2M share Spot Secondary priced at $116.00.
• SBA Communications (SBAC) Q3 adj. FFO/share $3.19 vs est $3.10 (beat); revenue $713.924Mm vs. est. $724.6Mm (miss); adj. EBITDA $488.1Mm vs est $490.24Mm (miss); site leasing revenue $665.4Mm and site development revenue $48.5Mm; lowers FY26 revenue outlook to $2.833-2.858B from $2.841-2.886B vs. est. $2.864B (miss); latest FY26 adj. FFO/share outlook $12.15-12.37 vs est $12.21; quarterly dividend $1.25/share.
• Walt Disney Co. (DIS) is moving toward thousands of job cuts with the entertainment giant asking some managers to target 20% in annual cost savings, according to people familiar with the matter, per Bloomberg

Mid-Morning Look

Tuesday, November 03, 2026

U.S. stocks open mixed and largely confirm the overnight split from the heavy slate of mega-cap tech earnings, with the Dow falling behind weakness in Apple (AAPL) post earnings/commentary about costs and margins, while the S&P 500 adds small gains and the Nasdaq outperforms early after tumbling 1% on Monday on more semi/AI related stock weakness. Apple (AAPL) shares pare their premarket slide, but still down after mixed December-quarter guidance and warned that rising memory costs would squeeze gross margins. Technology (XLK) leads the tape at +1% after falling about -3% Monday, followed by Industrials (XLI), Health Care (XLV) and Communication Services, while Consumer Staples (XLP) lags at -1.65%, pulling back from all-time highs alongside Materials (XLB) and Energy (XLE). The 10-year Treasury yield is back up to 4.93% after slipping overnight, the 30-year adds 3.8 basis points to 5.307%, the dollar index is little changed at 101.79, gold has bounced off its premarket lows but still down.

Oil prices have sharply reversed their overnight spike, with Brent down $1.39 to $103.38 a barrel and WTI off $0.61 to $95.85, giving back most of the early gains tied to the U.S. strike on Iran's Qeshm Island after headlines crossed that Washington has approved a draft memorandum of understanding and that mediators have briefed Saudi Arabia and the UAE, who have signed off on it, fueling hopes of a near-term de-escalation; Energy (XLE) is accordingly among today's weakest sectors.

Note the Nasdaq-100 closed more than 10% below its all-time closing high on Monday, confirming that the tech-heavy index has entered a correction as investors grow wary of Big Tech's soaring AI spending and little evidence of adequate returns. Chip stocks were among top gainers, bouncing back after the SOX fell well below its 200dma technical support Monday ahead of AMD results tonight.

• September U.S. job openings 7.523M vs. 7.160M consensus and 7.190M in August (revised from 7.079M); Number of quits: 3.365M vs. 3.044M (revised from 3.066M).
• US factory orders rose 1.8% in September, exceeding the 1.2% consensus forecast and accelerating from August's upwardly revised 0.3% gain.
• Orders excluding transportation increased 1.3%, while orders excluding defense jumped 2.0%, signaling broad-based manufacturing strength.
• Durable goods orders were revised higher to +1.9%, and core capital goods orders improved to +0.6%, with shipments rising 1.2%.

• Semiconductor sector: AI-exposed chipmakers extend gains on blowout quarters, with LSCC surging after management guided FY27 revenue growth of 60%-plus with backlog visibility into 2028; AEIS jumps 10.0% after a beat-and-raise quarter with Semi and data-center share gains; ON rises after results on accelerating AI data-center revenue (now seen doubling again in CY27); NVDA active even as the Financial Times reports it is directing data-center partners to cut exposure to Chinese customers; AMD on deck with earnings.
• Networking/Optical components sector: rebound in the broader sector as Wall Street digests the more than $100B all-stock tie-up between MRVL; TD Cowen downgraded shares of MRVL to Hold from Buy ($175 PT, from $350) on dilution and cyclical-peak concerns, while RBC Capital Markets kept Outperform but cut its target to $250 from $425; shares of AAOI, CIEN, COHR look to rebound; shares of FN help boost the sector after better results and guidance.
• Refiners sector: CVI tumbles 9.3% after launching a $750M common stock offering (alongside a related $500M CVI/$250M IEP Energy Holding share sale) to help fund its $4.20B acquisition of MPC St. Paul Park, Minnesota and Mandan, North Dakota refineries and marketing business; MPC slips 1.9% after topped Q3 estimates, as the market weighs the divestiture terms ($3.45B to MPC, $750M to MPLX at a 9x forward EBITDA multiple on the midstream assets).

• BLZE +34%; shares jump on results/guidance as sees Q4 revs $49.8M-$50.2M vs. est. $47M and raises year sales view to $177.8M-$178.2M from prior $172M-$174M; said broad-based customer momentum drove 47% yr/yr growth in B2 Cloud Storage revenue.
• ETN +7%; said Q3 results were driven by 19% organic sales growth, with broad end-market strength across Electrical Americas, Electrical Global and Aerospace and raises full-year 2026 organic growth guidance to 13-15% and better EPS view.
• FISV +6%; reported earnings and revs that topped consensus, raised its Project Elevate savings target, and said it cut its employee and contractor base by 3,000 since June, including a reduction of senior management by more than 10%.
• FN +12%; results and guidance are better; Q1 adj EPS $4.34 vs. est. $4.20 and Q1 revs $1.47B vs. est. $1.41B; guides Q2 adj EPS $4.77-$4.92 vs. est. 44.43 and revs $1.6B-$1.65B vs. est. $1.48B.
• GPK +14%; after reporting Q3 sales of $2.192B (vs. $2.171B est.) and adj. EPS of $0.23 (vs. $0.22 est.), with FY2026 guidance of $0.68 EPS on $8.63B revenue.
• RVTY +11%; after Q3 revenue of $729M beat the $698.2M estimate and adj. EPS of $1.37 topped the $1.30 estimate, with FY revenue guidance raised to $2.860B and adj. EPS guided to $5.40-$5.45, shares hitting their highest levels since April 2022.

• ADEA -16%; after lowers FY revenue forecast to $375M-$415M from prior view $395M-$435M and cuts FY adjusted net income forecast to $136.7M-$164.3M from prior $144.2M-$168.7M.
• BALL -6%; shares fell after swinging to Q3 loss after $475M non-cash pension settlement charge; Q3 net loss of $94M, compared with year-ago net income of $321M; did beat Q3 net sales, adj profit est on strong demand for beverage cans, higher shipments, favorable pricing.
• CVI -11%; after announcing a $750M common stock offering tied to its $4.2B MPC refinery acquisition.
• DT -14%; shares slide after results and lowered its FY27 adj. EPS forecast to $1.88-$1.90, down from prior forecast of $1.97-$1.99 and guides FY27 adj. cash flow of $600M-$605M, down from previous forecast of $610M-$615M, which followed weaker Q3 guide.
• KDP -6%; beats Q3 revenue and profit estimates, helped by steady demand for its energy drinks and carbonated soft beverages and reaffirmed guidance but said reduced prices in certain regions and products to reflect lower coffee costs during Q3.
• LDOS -5%; shares fall after the defense supplier trims FY26 revenue forecast to $18B-$18.2B from $18.2B-$18.4B prior (est. $18.26B) after Q3 revs misses (beat on EPS and guidance).
• MNDY -4%; was downgraded from Buy to Hold at TD Cowen and trim tgt to $105 saying top-of-funnel headwinds are growing & MNDY is pivoting more aggressively up-market, likely to result in greater pressure on its down-market business (~40% of ARR).
• SHOP -8%; after Q3 GMV of $119.145B, revenue of $3.742B and adj EPS of $0.49, with guidance for Q4 2026 gross profit dollars to grow at a high-twenties percentage rate YoY and free cash flow margin consistent with Q4 2025; the company also filed for a mixed shelf of undisclosed size.

Closing Recap

Monday, November 02, 2026

What initially looked like a promising start to the new trading month, U.S. stock markets pulled back off morning highs above 1% for most averages, as technology (XLK, SOX, QQQ) failed to hold the early gains amid another rout in semis and Ai related plays, continuing the October trend. Still, overall market breadth was positive with 8 of 11 S&P sectors higher, led by the names that rallied in October (Consumer Staples, REITs, Utilities, Financials). Technology (XLK -2.95%) and Energy (XLE -3.96%) were the biggest drags. Precious metals were a bright spot, bouncing off 1-year lows for gold and silver amid the pullback in oil prices. While tech remains the key overall market driver lower, attention turns this week to tomorrow’s midterm elections where Democrats are expected to flip the House Blue, while the Senate remains a toss up at this point, though prediction markets are forecasting a flip to Blue as well. Monthly jobs data also in focus with ADP private payrolls, JOLTs job openings and Nonfarm payrolls on the calendar this week. Tonight after the bell we see earnings from Apple Inc. (AAPL), coming off recent all-time highs before a heavy earnings calendar the remainder of the week with 29% of the S&P 500 due to report. The amazing part on this latest tech pullback comes as Treasury yields have come down notably from early October highs and oil prices a sharp downturn today.

• ISM U.S. manufacturing activity index 55.5 in October (consensus 54.5) vs 54.5 in September; prices paid index 75.2 in October vs 77.9 (consensus 77.5) in September; new orders index 55.5 in October vs 55.3 in September and employment index 52.4 in October (consensus 52.0) vs 52.7 in September
• September construction spending -1.9% (consensus +0.3%); US Sept construction spending -1.9% (consensus +0.3%) to $2.186 trln, vs Aug +2.0% (prev +0.9%); US Sept private construction spending -2.4%, public spending -0.1%.

• Gold prices rose $70.70 or 1.81% to settle at $3,969.60 an ounce, rebounding from a one-year low hit in the previous session, supported by a retreat in oil prices that tempered inflation worries, while investors awaited US midterm elections tomorrow. Silver prices rose $1.61 or 3.27% to settle at $50.89 an ounce. Oil prices fell more than 6% on Monday after Iran and Qatar held a third consecutive day of talks aimed at ending the US-Israeli war on Iran. Traders see a 77% chance of a US rate hike in December, down from 80% a week ago, according to CME Group's FedWatch Tool.

• The U.S. dollar eased as oil prices plunged and Treasury yields retreated ahead of a week full of catalysts, including the US midterm elections, a host of data on the US labor market and multiple central bank rate decisions. The dollar index (DXY) fell 0.22% to 101.76 after declining to 101.42, its lowest since September 30.

• Retail sector: NXH shares bounced after tZERO proposed business combination advances opportunity to scale regulated digital-asset infrastructure; NXH signs support agreement.
• Building Product sector: FND was downgraded to Sell from Neutral at Goldman Sachs and cuts PT to $38, as persistent housing pressure, slowing comps, and higher supply-chain costs limit the near-term earnings outlook. While the upcoming Pro loyalty program and longer-term store opportunity remain positives, expects housing turnover to stay pressured in FY27.
• Homebuilder stocks DHI, KBH, LEN, MTH, PHM, TOL advanced along with related mortgage names as Treasury yields extend recent pullbacks.

• Auto sector: RIVN was upgraded to Buy from Neutral at UBS with $17 tgt as sees the recent selloff (-19% over the past month vs S&P500 -1%) as a buying opportunity ahead of an inflection in R2 ramp and gross margins; EVGO shares jumped after SEC filing shows the company to be acquired by private co LS Power Equity Advisors for $2 per share.
• Chinese Ev sector: monthly delivery data out as LI delivered 29,025 vehicles in October 2026, representing a 43.6% Y/Y decline from 51,443 units in October 2025 and an 8.8% M/M drop from 31,817 units in September 2026; NIO delivered 34,246 electric vehicles in October 2026, representing an 8.4% M/M decline from September's 37,408 units and fell 15.2% Y/Y, while bringing its cumulative deliveries to 1,332,139 as of October 31. XPEV achieved a new monthly record with total deliveries of 50,237 electric vehicles in October 2026, representing a 22% M/M increase from September and a 20% Y/Y increase. Monthly performance was further bolstered by overseas deliveries, which reached an all-time monthly high of 13,326 units, up 166% Y/Y.

• Space sector: SPCX is reportedly in talks with ECHO over a potential acquisition of Boost Mobile or a deal to use its wireless network, as Elon Musk looks to launch a full-fledged U.S. cellphone service, the Washington Post reported. Musk previously approached Verizon (VZ), AT&T (T) and T-Mobile (TMUS) seeking access to their networks, but all three rejected the proposal.
• Material sector: ln lithium space (ALB, SQM, LIT), Citigroup said lithium prices to remain depressed in the near term after spot Lithium prices have fallen 40% since Sep'26, raising the key question of whether correction has run its course. While Citi sees declining salt inventories in China to provide near term support, price upside is likely to be capped. Citi sees little catalyst for a meaningful recovery in downstream activity at current prices.

• Consumer finance/payments sector: a big week ahead of the space with earnings expected from FISV, BR, TOST, FLYW, XYZ, FIS, JKHY, WU, CPAY, GPN, LSPD, FOUR, VYX, and AFRM all this week; shares of MA and Visa (V) both made new all-time highs today; AXP shares jumped topping its 200dma of $225.95 this morning in strong consumer finance space (COF as well).

• AXSM shares tumbled following Q3 earnings results.
• INO shares surged after the FDA approved its treatment INO-3107 (branded Voceryq) for a rare respiratory condition, marking the company's first approved product. Inovio expects Voceryq to be available for order and shipment within about 60 days, and commercial launch planned 1Q’27.
• QURE said announced FDA acceptance and priority review for its BLA for ifezuntirgene inilparvovec in Huntington’s Disease, with a 5/1/2027 PDUFA. The FDA is tentatively planning to hold an AdCom for the application.
• TEVA said it was discontinuing its mid-stage neurodegenerative disorder study due to a low probability of the study meeting its main goal if continued. The company was testing its experimental oral drug, emrusolmin, in adults with multiple system atrophy.
• Animal product sector: IDXX shares rose after Q3 top and bottom line beat, mgmt raising FY organic growth to 9.3%-10.0% vs prior guidance 8.5%-9.7%. Q3 EPS $4.01 vs $3.73 est. Q3 revs $1.21B vs $1.19B est. FY EPS guide $14.96-15.16 vs prior guidance $14.69-14.94.
• Precision medicine sector: TEM Q3 revs and adjusted EBITDA slightly above expectations, reaffirms FY adjusted EBITDA guide. Q3 revenue $411.5M vs $409M est. Q3 adj EBITDA $25.6M vs $18.6M est. FY26 rev guide $1.60-1.605B vs prior guidance $1.595-1.605B. Reaffirms adjusted EBITDA.
• Telehealth sector: TDOC was downgraded to Sell and then coverage dropped at Argus as the firm said Teladoc is struggling with challenges in a telemedicine industry that have many companies seeking to provide virtual health services/they forecast operating losses through 2027.

• Data Center sector: CIFR shares fell early after Q3 revenue fell y/y as bitcoin mining revenue declined though recognized first HPC lease revenue, marking shift in business strategy; Net profit posted for Q3, driven by non-operating gains; adjusted EBITDA was negative; said expects additional capacity at Black Pearl and other campuses to come online by year-end.

• Quantum sector: B Riley lowered prices tgts on IONQ to $75 from $100, QBTS to $27 from $40, RGTI to $25 from $35 and INFQ to $17 from $23 in earnings preview saying ecosystem progress continued, yet shares fell on sector and Ai weakness. IONQ with the first partial SkyWater quarter should show manufacturing, demand, validation, and funding progress, with consensus Q4; QBTS reports in a CFO transition quarter with gate-model and annealing progress in focus and RGTI looks like a trough Q3 ahead of its C-DAC system revenue recognition in Q4.
• Security Software sector: OKTA shares rose after being added to the S&P 500 index this week, replacing KVUE which is being acquired by KMB in a deal expected to be completed soon. CHKP shares slipped after Q3 revs fell -1.1% y/y to $669.8M vs. est. $672M, while security subscriptions revenue rose 11% to $339M. Remaining performance obligations increased 5% to $2.5B. CRWD was upgraded to buy from Hold at Deutsche bank and raised tgt to $300 from $240 as believe investors are still not fully appreciating the extent to which Ai will expand the market for cybersecurity and CrowdStrike’s leadership at the forefront.

• TSEM reported better-than-expected Q3 earnings and revenue and forecast fourth-quarter sales above analysts' estimates, citing strong demand for high-speed connectivity products; expects Q4 revenue of $600M, plus or minus 5%, vs. estimates of about $580M as midpoint of the forecast represents growth of 36% y/y and 14% from the prior quarter.

Street Recommendations

Tuesday, November 3, 2026

• LIFE Barclays analyst Ross Sandler raised the firm's price target on Ethos to $44 from $37 and keeps an Overweight rating on the shares following the earnings report. Ethos "continues to post impressive growth rates amidst challenges across the end market," the analyst tells investors in a research note. Barclays thinks this can continue for the "foreseeable future."
• FIGS Barclays analyst Adrienne Yih raised the firm's price target on Figs to $24 from $20 and keeps an Overweight rating on the shares. The firm remains positive on Figs, saying its brand heat remains strong given its above average higher-income cohort exposure.
• JAZZ Barclays analyst Etzer Darout raised the firm's price target on Jazz Pharmaceuticals to $275 from $271 and keeps an Overweight rating on the shares. The company's Q3 performance shows a durable neuro base business with Ziihera upside given the strong launch, the analyst tells investors in a research note.
• MAR Barclays raised the firm's price target on Marriott to $409 from $363 and keeps an Equal Weight rating on the shares following the Q3 report. The company posted strong U.S. core growth and sales, which overshadow owner and key-money related risk, the analyst tells investors in a research note.
• PAG Barclays analyst John Babcock raised the firm's price target on Penske Automotive to $212 from $210 and keeps an Overweight rating on the shares post the Q3 report. The company delivered a same-store sales performance at the upper end of peers, the analyst tells investors in a research note.
• BE Barclays upgraded Bloom Energy to Overweight from Equal Weight with a price target of $289, down from $316. The firm says Bloom's accelerating capacity build, rising customer deposits and new supply commitments indicate the company's demand is ramping faster than expected. Barclays says Bloom's demand trends are "getting harder to ignore." According to TipRanks, Barclays has a 1-star analyst on Bloom Energy. [View TipRanks Star Ranking]:[https://www.tipranks.com/experts/analysts/christine-cho]

• AJG BMO Capital analyst Michael Zaremski downgraded Arthur J. Gallagher to Market Perform from Outperform with a price target of $295, up from $255. The firm prefers the insurance brokers with exposure to large-employers. These brokers will exhibit organic growth that's less correlated with property and casualty pricing-power, the analyst tells investors in a research note. BMO expects P&C pricing-power to continue to decelerate in 2027. It adjusted three ratings as a result. The firm cites valuation for the downgrade of Arthur J. Gallagher, recommending taking profits following the recent rally.

• PIPR BofA analyst Gabriel Angelini lowered the firm's price target on Piper Sandler to $69 from $75 and keeps an Underperform rating on the shares. Shares fell sharply intra-day Friday, which the firm would attribute to a disappointing fourth quarter outlook, says the analyst, who reduced the firm's Q4 EPS view to $1.16 from $1.55 and 2027 forecast to $4.63 from $4.99.
• AXSM BofA lowered the firm's price target on Axsome Therapeutics to $264 from $276 and keeps a Buy rating on the shares. Q3 was largely in-line, but shares continue to underperform on concerns about the Alzheimer's disease agitation launch pace and support for 2027 consensus, says the analyst, who views the pullback as overdone given increasingly de-risked major depressive disorder and ADA upside.
• EL BofA raised the firm's price target on Estee Lauder to $126 from $120 and keeps a Buy rating on the shares. The firm raised adjusted EPS estimates by 4%-5% in FY27-28, driven mostly by higher gross margin, which puts its forecasts above the top end of the company's raised guidance, the analyst tells investors.
• TSEM BofA lowered the firm's price target on Tower Semiconductor to $310 from $367 and keeps a Buy rating on the shares after the company reported a Q3 beat, noted capacity expansion plans ahead of schedule, and customer contracts now extending into 2029. However, the firm lowered its FY26-28 revenue estimates by 1%-6% and adjusted margins, driving its price target change.
• CRBG BofA raised the firm's price target on Corebridge to $45 from $44 and keeps a Buy rating on the shares. The firm's EPS estimates "fall modestly" as the Q3 results flow through its model, but it raised its price target on a higher peer multiple for the life insurance peer group.

• TCMD BTIG lowered the firm's price target on Tactile Systems to $31 from $35 and keeps a Buy rating on the shares after its Q3 earnings miss. Lymphedema grew about 13% Y/Y, though Airway Clearance decreased 25% Y/Y due to inventory draw-downs ahead of a next-gen product launch, the analyst tells investors in a research note.

• EVER Canaccord raised the firm's price target on EverQuote to $32 from $28 and keeps a Buy rating on the shares. The firm said EverQuote reported strong Q3 results, with revenue and adj. EBITDA both coming in well above consensus and the upper end of guidance. Auto revenue grew in the low twenties year-over-year as continued strong underwriting profitability supported broad-based carrier demand, with eight of EverQuote's top ten carriers growing sequentially.
• NBIX Canaccord raised the firm's price target on Neurocrine to $220 from $210 and keeps a Buy rating on the shares. The firm updated its model following Q3 results thst showed solid execution contnued whiel awaiting key pipeline catalysts. The feels the shares are undervalued on marketed products as the pipeline builds steamfor next year.

• VRTX Cantor Fitzgerald raised the firm's price target on Vertex Pharmaceuticals to $619 from $595 and keeps an Overweight rating on the shares. Vertex reinforced confidence in povetacicept ahead of its November 30 IgAN PDUFA, downplaying concerns around the Citizen Petition, highlighting on-schedule FDA interactions and reiterating enthusiasm for the clinical data, the analyst tells investors in a research note.
• EPRT Cantor Fitzgerald lowered the firm's price target on Essential Properties Realty Trust to $31 from $37 and keeps an Overweight rating on the shares. Essential Properties raised the low end of its 2026 AFFO guidance and introduced a favorable 2027 outlook for approximately 5% growth despite a tougher capital environment and slower investment pace, supported by $483M in unsettled forward equity, acquisition cap rates above 8% and strong tenant credit, the analyst tells investors in a research note.
• CIFR Cantor Fitzgerald analyst Brett Knoblauch lowered the firm's price target on Cipher Mining to $15 from $19 and keeps an Overweight rating on the shares. Cipher Mining's Q3 results were largely as expected as Bitcoin mining capacity shifts toward AI, while the extended Barber Lake lease is viewed as NPV-positive despite near-term capital costs and lower initial returns, the analyst tells investors in a research note.

• CHTR Citi analyst Michael Rollins lowered the firm's price target on Charter to $140 from $180 and keeps a Buy rating on the shares. The firm updated the company's model to reflect dilution from a higher cost of capital and a tougher operating environment.
• PLTR Citi raised the firm's price target on Palantir to $265 from $250 and keeps a Buy rating on the shares. The company reported "another top-line blowout" in Q3, driven by strength in U.S. commercial and government, the analyst tells investors in a research note. Citi views Palantir's Q3 as strong despite a duration headwind to bookings.
• AAPL Citi keeps a Buy rating on Apple with a $365 price target following the fiscal Q4 report. The quarter beat estimates but the Q1 outlook is mixed relative to expectations with higher product revenues, partially offset by lower Services growth and lower gross margins, the analyst tells investors in a research note. Citi remains constructive on Apple's long-term trajectory despite the mixed outlook. It views Apple as "defensive stock."
• PBR Citi added an "upside 30-day catalyst watch" on Petrobras while keeping a Neutral rating on the shares with a $21.50 price target. The firm sees a favorable operational outlook for the company given high oil and gas production, elevated crack spreads, and ongoing supply disruptions.
• SBAC Citi analyst Michael Rollins lowered the firm's price target on SBA Communications to $225 from $235 and keeps a Buy rating on the shares. The company's domestic leasing results in Q3 slightly missed expectations, the analyst tells investors in a research note.

• MAR Goldman Sachs analyst Lizzie Dove raised the firm's price target on Marriott to $456 from $406 and keeps a Buy rating on the shares. Marriott delivered a broad Q3 beat and meaningfully stronger Q4 guidance, with improved RevPAR translating fully into EBITDA and 2027 systemwide RevPAR growth projected at 3.5%-4.5%, though slower non-RevPAR fee growth and lower owned and leased EBITDA are expected to temper next year's performance, the analyst tells investors in a research note.
• TYL Goldman Sachs raised the firm's price target on Tyler Technologies to $385 from $345 and keeps a Neutral rating on the shares. Tyler's revenue missed Street expectations slightly, margins were in line and FY26 guidance was trimmed, but strong on-premise customer engagement ahead of expected 2027 cloud migration acceleration and early AI traction, with 300 deals year-to-date, support its longer-term positioning, the analyst tells investors in a research note.
• FLNC Goldman Sachs analyst Brian Lee lowered the firm's price target on Fluence Energy to $7 from $9 and keeps a Neutral rating on the shares. Fluence appointed interim CEO Axel Meier and interim CFO Ricardo Roizen and established board-level manufacturing oversight as it works through an operational reset, with backlog intact and Q4 bookings expected to remain strong,the analyst tells investors in a research note.

• HLIT Jefferies analyst Blayne Curtis lowered the firm's price target on Harmonic to $13 from $15 and keeps a Hold rating on the shares despite "another strong quarter" and the calendar 2026 outlook being raised again to $550M at the midpoint. Total book-to-bill "bears watching," but the firm views the improving customer mix as reducing concentration risk into calendar 2027, the analyst tells investors.

• VRTX JPMorgan raised the firm's price target on Vertex Pharmaceuticals to $570 from $560 and keeps an Overweight rating on the shares. The firm views the company's Q3 results as solid overall. The firm expects the near-term focus will remain on povetacicep, and it is highly confident in an on-time approval in immunoglobulin A nephropathy.
• SBAC JPMorgan lowered the firm's price target on SBA Communications to $200 from $220 and keeps a Neutral rating on the shares following the Q3 report. The company slightly reduced 2026 guidance for site leasing revenue, tower cash flow, and adjusted EBITDA, reflecting the sale of the company's Chile and Ecuador businesses, as well as currency impacts, the analyst tells investors in a research note.
• CIFR JPMorgan analyst Richard Choe lowered the firm's price target on Cipher Mining to $18 from $22 and keeps an Overweight rating on the shares post the Q3 report. The company is now executing on its signed contracts and has fully funded its development of signed contracts, which will be delivered by mid-2027, the analyst tells investors in a research note. JPMorgan views Cipher shares as "substantially undervalued."
• AAPL JPMorgan lowered the firm's price target on Apple to $355 from $360 and keeps an Overweight rating on the shares following the fiscal Q4 report. The primary investor discussion around Apple shares following the earnings print will likely be around the changing trajectory of hardware versus services growth, the analyst tells investors in a research note. The firm says that despite concerns around supply constraints and price elasticity following significant price increases, Apple product and iPhone revenues have delivered to expectations. On the flip-side, the company has seen a steady moderation in the growth rate for services, which is increasingly going to call into question the long-term services growth rate when faced with mobile gaming headwinds, contends JPMorgan.
• NET JPMorgan analyst Samik Chatterjee upgraded Cloudflare to Overweight from Neutral with an unchanged price target of $350. The firm cites valuation for the upgrade following the stock's 20% pullback over the past month. Cloudflare remains well positioned to benefit from the scaling of Act I and Act II with existing customers and the pace of wins for Workers amid traction from developers, the analyst tells investors in a research note. JPMorgan believes Cloudflare can accelerate revenue growth in the medium term to 35%-plus. According to TipRanks, JPMorgan has a 5-star analyst on Cloudflare. [View TipRanks Star Ranking]:[https://www.tipranks.com/experts/analysts/samik-chatterjee]

• JD Mizuho lowered the firm's price target on JD.com to $37 from $39 and keeps an Outperform rating on the shares. The firm says its latest checks across China internet indicate AI demand continues to broaden while competitive spending is becoming more disciplined.
• HGV Mizuho analyst Ben Chaiken lowered the firm's price target on Hilton Grand Vacations to $60 from $74 and keeps an Outperform rating on the shares. The company's results were lower than expected but the stock's risk/reward remains supportive, the analyst tells investors in a research note.

• PLTR Morgan Stanley analyst Sanjit Singh raised the firm's price target on Palantir to $233 from $205 and keeps an Equal Weight rating on the shares. While "impressive" that revenue growth accelerated for the 13th quarter in a row to 96% year-over-year, a muted stock reaction reflects higher U.S. commercial expectations and a slowdown in bookings metrics attributed to shorter duration contracts, the analyst tells investors.
• GD Morgan Stanley raised the firm's price target on General Dynamics to $480 from $465 and keeps an Overweight rating on the shares following what the firm calls "another strong beat-and-raise quarter." Marine gains, Gulfstream's ramp, and allied demand support multi-year growth, the analyst tells investors.
• JAZZ Morgan Stanley raised the firm's price target on Jazz Pharmaceuticals to $319 from $314 and keeps an Overweight rating on the shares. The oxybate franchise is holding up better than Jazz itself planned, the analyst tells investors in a post-earnings note.
• NBIX Morgan Stanley raised the firm's price target on Neurocrine to $185 from $183 and keeps an Equal Weight rating on the shares. Neurocrine posted record Q3 net product sales on an Ingrezza beat that drove a second FY26 guidance raise, the analyst tells investors in a post-earnings note.
• BMRN Morgan Stanley analyst Sean Laaman lowered the firm's price target on BioMarin to $119 from $122 and keeps an Overweight rating on the shares. BioMarin delivered its first quarter above $1B in revenue, in line with consensus, while cutting FY26 total revenue guidance due to a roughly $70M order deferral by a single international customer attributed to timing rather than patient demand, the analyst tells investors.
• EL Morgan Stanley raised the firm's price target on Estee Lauder to $118 from $112 and keeps an Equal Weight rating on the shares. Moving beyond short-term expectations and investor focus on any risk from weaker consumer spending, the firm continues to be impressed by the turnaround put in place by the company's relatively new management team, the analyst tells investors.
• VRTX Morgan Stanley analyst Terence Flynn lowered the firm's price target on Vertex Pharmaceuticals to $660 from $665 and keeps an Overweight rating on the shares after "generally in line" Q3 results and and 2026 revenue guidance that was "raised a touch" on the inclusion of Palsonify sales following the Crinetics deal. "More importantly," Vertex sounded confident in FDA approval for povetacicep ahead of the PDUFA date of November 30 for immunoglobulin A nephropathy, the analyst tells investors.
• AEIS Morgan Stanley lowered the firm's price target on Advanced Energy to $368 from $375 and keeps an Overweight rating on the shares, which were also named the analyst's Top Pick. Earnings showcased the company's execution, says the analyst, who thinks the stock "presents the best risk-reward in US SPE." The bar for "gaining share" in both SPE and data center power is approximately 40%, and Advanced is "delivering on both fronts," the analyst added.

• PTEN Piper Sandler analyst Derek Podhaizer raised the firm's price target on Patterson-UTI to $15 from $14 and keeps an Overweight rating on the shares. The firm notes the company's management continued to message confidence in the outlook for the business, with activity up significantly.
• WHD Piper Sandler raised the firm's price target on Cactus to $78 from $75 and keeps an Overweight rating on the shares. The firm says the company is seeing strength in its Spoolable Technologies segment with Cactus announcing its plans to build a manufacturing facility in the Middle East, which management highlighted as a strong opportunity and one of the largest potential markets for Spoolable pipe, noting that Steel pipe currently dominates in that region.
• INSP Piper Sandler raised the firm's price target on Inspire Medical to $70 from $60 and keeps a Neutral rating on the shares. The firm notes the company reported a Q3 beat with revenue of $206.7M vs. the Street's $204.5M forecast, while adjusted EPS of 14c compared to the Street's 11c bogey. Management narrowed its FY2026 revenue guidance of $835M-$875M to $850M-$860M.
• NBIX Piper Sandler raised the firm's price target on Neurocrine to $215 from $210 and keeps an Overweight rating on the shares. The firm notes Neurocrine reported Q3 diluted GAAP EPS of $1.96 on revenue of $1.12B, compared to Street estimates of $1.91 and $1.04B, respectively. Piper thinks Neurocrine shares are valued attractively at an EV/2027 EBITDA of about 10-times.

• VVX RBC Capital raised the firm's price target on V2X to $88 from $81 and keeps a Sector Perform rating on the shares. The company reported strong Q3 results with organic growth of 9%, ad V2X continues to call out strength in the Asia Pacific region, even as it continues to face headwinds with its Middle East revenues, the analyst tells investors in a research note.
• EL RBC Capital analyst Nik Modi raised the firm's price target on Estee Lauder to $126 from $120 and keeps an Outperform rating on the shares. The company posted solid results to start its fiscal year, with outperformance across all regions and all major P&L line item, the analyst tells investors in a research note. As the topline is exhibiting positive growth, cost and operational efficiencies from the company's PRGP - Profit Recovery and Growth Plan - plan and the benefit of sales leverage are shining through to margins and ultimately EPS, RBC added.
• ENSG RBC Capital raised the firm's price target on Ensign Group to $239 from $228 and keeps an Outperform rating on the shares. The company delivered another strong quarter and remains among the firm's top picks in post-acute coverage., the analyst tells investors in a research note. Ensign has also entered the Florida market and the firm has come away from its call with management confident in the company's local leadership in the state and its ability to navigate the ramp, RBC added.
• PLTR RBC Capital analyst Rishi Jaluria raised the firm's price target on Palantir to $130 from $90 and keeps an Underperform rating on the shares. The company delivered a solid Q3 result with revenue up 96% y/y, the analyst tells investors in a research note. Palantir FY26 guidance was raised across all metrics, though the firm remains watchful as total RDV - remaining deal value - grew just 2% from Q2, RPO was flat sequentially, and the management acknowledged shorter-than-usual contract durations in Sovereign AI, the firm added.
• NBIX RBC Capital analyst Brian Abrahams raised the firm's price target on Neurocrine to $190 from $187 and keeps an Outperform rating on the shares after its Q3 earnings beat. Strong commercial execution for the core legacy programs being driven by demand, coupled with a nice bounceback quarter for Vykat, should help to begin turning sentiment around and closing a substantial gap vs. fundamental fair value, the analyst tells investors in a research note.

• LSCC Rosenblatt raised the firm's price target on Lattice Semiconductor to $200 from $175 and keeps a Buy rating on the shares. The company reported a strong quarter but the bigger takeaway was its fiscal 2027 revenue growth outlook of 60%-plus, supported by backlog extending into the first half of 2028, the analyst tells investors in a research note. The firm says Lattice is benefiting from rising field programmable gate array content and attach rates in AI servers, as well as a broadening industrial recovery.
• SITM Rosenblatt analyst Sajal Dora raised the firm's price target on SiTime (SITM) to $900 from $750 and keeps a Buy rating on the shares ahead of the company reporting fiscal Q3 results after the close on Wednesday, November 4. The firm expects a strong September quarter and December quarter guidance above consensus estimates as Apple's (AAPL) internal-modem ramp more than offsets iPhone build cuts, the analyst tells investors in a preview.

• CP Susquehanna raised the firm's price target on Canadian Pacific Kansas City to $105 from $98 and keeps a Positive rating on the shares. The Canadian rails sustained volume growth through Q3 on a strong intermodal quarter, the analyst tells investors in a research note.
• CHKP Susquehanna raised the firm's price target on Check Point to $165 from $150 and keeps a Positive rating on the shares. The firm said they posted mixed 3Q results and a 4Q outlook that points to a more gradual recovery, though management believes product revenue has troughed. Improving execution following its GTM changes and continued traction with its emerging product suite are encouraging.

• CYH Wells Fargo analyst Stephen Baxter lowered the firm's price target on Community Health to $1 from $2 and keeps an Underweight rating on the shares. The firm is also lowering estimates after weak Q3 results and lowered guidance.
• CHKP Wells Fargo analyst Richard Poland raised the firm's price target on Check Point to $135 from $130 and keeps an Equal Weight rating on the shares. With Q4 guide-down out the way, the firm expects debate shifts to shape of 2027 recovery on price raise, new logo capacity and sustained 11% subscription growth. Wells struggles to underwrite much upside to 4%-5% growth base case, likely keeping shares range-bound.
• CIFR Wells Fargo lowered the firm's price target on Cipher Mining to $15 from $25 and keeps an Overweight rating on the shares. The firm notes the company's Q3 results came with few surprises, ahead of delivery of its 3 campuses - while Cipher also takes steps to de-risk the next round of leases into its 6 GW pipeline. Wells believes risk/reward still favorable.
• CLX Wells Fargo raised the firm's price target on Clorox to $90 from $85 and keeps an Equal Weight rating on the shares. The firm continues to see EPS within its prior range, albeit at now the lower end, implying profit growth ramps in the second half of the year, especially vs Q2 which is implied to be a challenging quarter. This profit ramp feels like a key debate after today, namely with a new CEO by Q2, Wells adds.
• VRTX Wells Fargo analyst Mohit Bansal raised the firm's price target on Vertex Pharmaceuticals to $650 from $550 and keeps an Overweight rating on the shares. The firm says management sounded positive on Pove CMC and label concerns, making Wells comfortable around November 30th PDUFA. With CF competitor overhang removal and pipeline progress, the firm thinks Vertex is becoming a long-term story to own.
• AEIS Wells Fargo lowered the firm's price target on Advanced Energy to $310 from $360 and keeps an Overweight rating on the shares. The firm notes the company delivered another strong beat / raise driven by continued upside in Semi & data center. While ability to navigate supply constraints will be a focus, Wells believes Advanced Energy can continue to deliver strong growth in 2027.
• ON Wells Fargo lowered the firm's price target on Onsemi to $90 from $100 and keeps an Overweight rating on the shares. The firm notes results were somewhat mixed. Wells believes continued demand acceleration and gross margin percentage leverage remain key drivers of shares.
• OLN Wells Fargo raised the firm's price target on Olin to $17 from $16 and keeps an Equal Weight rating on the shares. The firm remains on the sidelines given challenging near-term chlor alkali fundamentals, coupled with turnaround expenses in CAPV & Epoxy, plus cost headwinds in Winchester.
• INSP Wells Fargo raised the firm's price target on Inspire Medical to $69 from $56 and keeps an Equal Weight rating on the shares. The firm notes the company reported slight Q3 revenue beat and narrowed 2026 guide. Initial 2027 outlook of low single digit growth is slightly below consensus, and year-over-year revenue decline is expected to continue into Q1 2027.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

• 10:00 AM ET                 Construction Spending for September
• 10:00 AM ET ISM Manufacturing PMI for October

• Earnings After the Close: AAPL ADTN AEHR AEIS ALG ALSN APPS BCC BLZE BMRN BRCC BSM BVS BWXT CALX CBT CC CE CERS CLX CRBG CRC CRGY CSR CSWC CWH DHC DOC EBS EQH ESRT EVER FANG FN GAIA HLF HLIT HNGE HSTM HUN ICHR IIPR INSP IRT JAZZ LSCC MSA MTCH NBIX NMFC O OGS ON OPAD OTTR PAY PLOW PLTR PS RHP RIG ROKU RXRX SBAC SBRA SIBN SITC SNDX TBBB TNC TTI TVTX UDR UPWK UTL VAL VNO VNOM VOYA VRTX VTS VVX WAY WMB

• 8:55 AM ET                   Johnson/Redbook Weekly Sales
• 10:00 AM ET                 Durable Goods, M/M for September
• 10:00 AM ET                 JOLTs Job openings for September
• 10:00 AM ET                 Factory Orders M/M for September
• 4:30 PM ET API Weekly Inventory Data

• Earnings After the Close: ACEL ADUS AFG AIG AIZ ALAB ALIT AMD AMGN AMWL ANDE ANET ANGI AQST ARDX ASH ATRC BKNG BXC CAR CBLL CHCT CORT CPNG CRCT CURLF CXDO DEI DOX DRH DUOL EVTC FBIN FLYW FRSH FTEK FTK GEF GOOD GSM GXO HL HMN HURN IFF IOSP IPI ITUB JELD JKHY JXN KODK LMB LTC MCY METC MIRM MOD MOS MQ MTDR MTW NVTS OHI OUST OVV PARR PCOR PRIM PRU PXED QDEL RARE RRR RWT RYAM SAFE SDRL SGHC SKY SM SMCI SPT SU SWIM SWKS TALO TOST TREE TRVG TSLX UFCS UNM USNA VRNS WTRG XYZ ZVRA

• 8:15 AM ET ADP Private Payrolls for October
• 8:30 AM ET                   Advance Goods Trade Balance for September
• 8:30 AM ET                   International Trade for September
• 9:45 AM ET S&P Global Composite PMI, Oct-final
• 9:45 AM ET S&P Global Services PMI, Oct-final
• 10:00 AM ET ISM Non-Manufacturing PMI for October
• 10:30 AM ET                 Weekly EIA Inventory Data

• Earnings After the Close: ACAD ACHC ACT ADPT AEVA AFL AGL AKA ALB ALGT ALL ALNT ALTO AMC AMCR AMH AMPL APA APC APP ARAY ARDT ATNI ATO AWR BBSI BIO BKH BROS BYND CAI CAPL CDE CDRE CF CGNX CHRD CHYM CLOV CODI COHR COOK COTY CPAY CPS CRK CRUS CW CXT CXW CYTK DASH DAVE DDD DHX DLX ECOR EE EGHT EHTH ELF EOLS ERII ES EW EXPE FC FICO FIG FSLY GNK GNL GNW GOLD GPOR GRAL GT GTM HCC HUBS INSG IPAR ITT JOBY KE KVYO LB LEU LILA LOPE LUMN LZ MAC MATX MBI MCK MELI MET MGNI MKSI MRVI MSI MTG MUR MWA MX MYGN NAVI NGVT NTGR MTR NVST NWSA OEC OM ORA PAAS PACB PAHC PAYC PCY PGNY PK PLMR POWI PRI PTC QCOM QGEN QNST RCUS RDN RELY RGLD RGR RLAY RPD RRGB RUN RVMD RYN SBGI SDGR SEI SEZL SITM SKT SNAP STAA STE TBI TDUP TKO TROX TS UHAL UIS UPLD UVV VCTR VECO VIAV VIR VSEC WES WOLF WTS WU XPER XRN Z ZG ZVIA

• 8:30 AM ET                   Weekly Jobless Claims
• 8:30 AM ET                   Continuing Claims
• 8:30 AM ET                   Nonfarm productivity for Q3-prelim
• 8:30 AM ET                   Unit Labor Costs for Q3-prelim
• 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data

• Earnings After the Close: AAOI ABNB ABX ACH AEE AFRM AGM AGO AHR AKAM ALLO ALRM AMN AMPH AORT AOSL APLE ARCT ARLO ARRY ASLE ATEN AXON BARK BILL BJRI BL BLNK BTE CABO CARG CART CBL CELC CENX CLAR CLNE CNDT COMP CON CPK CPT CRSR CSTL CTMX CTRE CYRX DBX DIOD DKNG DOCS DVN ED EGAN EOG ETON EVC EVCM EXFY FIGS FIVN FNF FNKO FOXF FROG G GH GMED GPRE GSBD HALO HASI HCAT HHH HNST HY IAG ICFI ICUI INOD INSE IONQ IREN IRTC JHX KINS KRMN KRT KRUS KTOS LASR LIDR LION LITE LOCO LYFT LYVMAIN MAT MC MCHP MNST MP MTD NET NGL NOG NTRA NUS NXH OMDA OPEN OUT PAR PBA PCTY PDFS PRAA PSIX QNT QSI REG REI RGA RILY SG SI SKIN SKWD SMR SOUN SPG SRPT SSP STEP TDC TEAM TMDX TNDM TRUP TXG TXRH UMAC VERA VSTM WEST WHG WK WLDN WPM WSC WYNN XPOF XRAY YELP ZD

• 8:30 AM ET                   Private Payrolls for October
• 8:30 AM ET                   Manufacturing Payrolls for October
• 8:30 AM ET                   Unemployment Rate for October
• 8:30 AM ET                   Average Hourly earnings M/M for October
• 10:00 AM ET                 University of Michigan Confidence, Nov-prelim
• 10:00 AM ET                 University of Michigan 1-yr and 5-yr inflation expectations
• 1:00 PM ET                    Baker Hughes Weekly rig count data

• Earnings After the Close: BH HE